Zometa Jaw Bone Death Awareness Program Should Be Enhanced – Cmte.

FDA's Oncologic Drugs Advisory Committee recommends that distribution of Novartis' "Dear Doctor" letter for Zometa and Aredia be extended to include dentists. Aggressive promotion of the bisphosphonates should also be curtailed, committee members suggest.